TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.260
-0.050 (-3.82%)
At close: Apr 28, 2026, 4:00 PM EDT
1.320
+0.060 (4.76%)
Pre-market: Apr 29, 2026, 7:30 AM EDT
TScan Therapeutics Employees
TScan Therapeutics had 142 employees as of December 31, 2025. The number of employees decreased by 53 or -27.18% compared to the previous year.
Employees
142
Change (1Y)
-53
Growth (1Y)
-27.18%
Revenue / Employee
$72,711
Profits / Employee
-$913,845
Market Cap
75.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 85 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Gain Therapeutics | 21 |
TCRX News
- 1 day ago - TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting - GlobeNewsWire
- 13 days ago - TScan Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 21 days ago - TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - TScan Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 - GlobeNewsWire
- 2 months ago - TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 5 months ago - TScan Therapeutics Transcript: KOL Event - Transcripts